Logo image of 6D81.DE

DUPONT DE NEMOURS INC (6D81.DE) Stock Fundamental Analysis

FRA:6D81 - Deutsche Boerse Ag - US26614N1028 - Common Stock - Currency: EUR

58.48  +0.04 (+0.07%)

Fundamental Rating

5

Overall 6D81 gets a fundamental rating of 5 out of 10. We evaluated 6D81 against 69 industry peers in the Chemicals industry. 6D81 has only an average score on both its financial health and profitability. 6D81 is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

6D81 had positive earnings in the past year.
6D81 had a positive operating cash flow in the past year.
6D81 had positive earnings in 4 of the past 5 years.
In the past 5 years 6D81 always reported a positive cash flow from operatings.
6D81.DE Yearly Net Income VS EBIT VS OCF VS FCF6D81.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B

1.2 Ratios

6D81 has a Return On Assets of -0.21%. This is comparable to the rest of the industry: 6D81 outperforms 40.58% of its industry peers.
6D81's Return On Equity of -0.33% is in line compared to the rest of the industry. 6D81 outperforms 40.58% of its industry peers.
The Return On Invested Capital of 6D81 (4.51%) is better than 62.32% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 6D81 is below the industry average of 6.66%.
The 3 year average ROIC (3.52%) for 6D81 is below the current ROIC(4.51%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.21%
ROE -0.33%
ROIC 4.51%
ROA(3y)5.74%
ROA(5y)5.44%
ROE(3y)8.95%
ROE(5y)8.73%
ROIC(3y)3.52%
ROIC(5y)3.04%
6D81.DE Yearly ROA, ROE, ROIC6D81.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

In the last couple of years the Profit Margin of 6D81 has grown nicely.
6D81's Operating Margin of 17.31% is amongst the best of the industry. 6D81 outperforms 88.41% of its industry peers.
6D81's Operating Margin has improved in the last couple of years.
6D81 has a Gross Margin of 37.26%. This is comparable to the rest of the industry: 6D81 outperforms 55.07% of its industry peers.
6D81's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.31%
PM (TTM) N/A
GM 37.26%
OM growth 3Y0.59%
OM growth 5Y3.81%
PM growth 3Y-52.04%
PM growth 5Y12.01%
GM growth 3Y0.02%
GM growth 5Y0.86%
6D81.DE Yearly Profit, Operating, Gross Margins6D81.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

4

2. Health

2.1 Basic Checks

6D81 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for 6D81 has been reduced compared to 1 year ago.
Compared to 5 years ago, 6D81 has less shares outstanding
The debt/assets ratio for 6D81 has been reduced compared to a year ago.
6D81.DE Yearly Shares Outstanding6D81.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
6D81.DE Yearly Total Debt VS Total Assets6D81.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

Based on the Altman-Z score of 0.97, we must say that 6D81 is in the distress zone and has some risk of bankruptcy.
6D81's Altman-Z score of 0.97 is on the low side compared to the rest of the industry. 6D81 is outperformed by 79.71% of its industry peers.
6D81 has a debt to FCF ratio of 6.43. This is a slightly negative value and a sign of low solvency as 6D81 would need 6.43 years to pay back of all of its debts.
The Debt to FCF ratio of 6D81 (6.43) is better than 65.22% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that 6D81 is not too dependend on debt financing.
6D81's Debt to Equity ratio of 0.23 is fine compared to the rest of the industry. 6D81 outperforms 69.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 6.43
Altman-Z 0.97
ROIC/WACC0.54
WACC8.32%
6D81.DE Yearly LT Debt VS Equity VS FCF6D81.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B 100B

2.3 Liquidity

6D81 has a Current Ratio of 1.40. This is a normal value and indicates that 6D81 is financially healthy and should not expect problems in meeting its short term obligations.
6D81 has a Current ratio of 1.40. This is in the lower half of the industry: 6D81 underperforms 66.67% of its industry peers.
A Quick Ratio of 0.91 indicates that 6D81 may have some problems paying its short term obligations.
6D81's Quick ratio of 0.91 is on the low side compared to the rest of the industry. 6D81 is outperformed by 68.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.91
6D81.DE Yearly Current Assets VS Current Liabilites6D81.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

4

3. Growth

3.1 Past

6D81 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.66%, which is quite impressive.
6D81 shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.50% yearly.
Looking at the last year, 6D81 shows a small growth in Revenue. The Revenue has grown by 4.51% in the last year.
The Revenue has been decreasing by -4.31% on average over the past years.
EPS 1Y (TTM)25.66%
EPS 3Y-1.04%
EPS 5Y-5.5%
EPS Q2Q%30.38%
Revenue 1Y (TTM)4.51%
Revenue growth 3Y-0.48%
Revenue growth 5Y-4.31%
Sales Q2Q%4.61%

3.2 Future

Based on estimates for the next years, 6D81 will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.20% on average per year.
6D81 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.21% yearly.
EPS Next Y7.6%
EPS Next 2Y8.32%
EPS Next 3Y8.99%
EPS Next 5Y8.2%
Revenue Next Year3.2%
Revenue Next 2Y3.65%
Revenue Next 3Y3.98%
Revenue Next 5Y4.21%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
6D81.DE Yearly Revenue VS Estimates6D81.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B 80B
6D81.DE Yearly EPS VS Estimates6D81.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.55, the valuation of 6D81 can be described as correct.
Based on the Price/Earnings ratio, 6D81 is valued a bit cheaper than 73.91% of the companies in the same industry.
When comparing the Price/Earnings ratio of 6D81 to the average of the S&P500 Index (26.34), we can say 6D81 is valued slightly cheaper.
With a Price/Forward Earnings ratio of 14.06, 6D81 is valued correctly.
Based on the Price/Forward Earnings ratio, 6D81 is valued a bit cheaper than the industry average as 60.87% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of 6D81 to the average of the S&P500 Index (22.19), we can say 6D81 is valued slightly cheaper.
Industry RankSector Rank
PE 15.55
Fwd PE 14.06
6D81.DE Price Earnings VS Forward Price Earnings6D81.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as 6D81.
62.32% of the companies in the same industry are more expensive than 6D81, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 25.19
EV/EBITDA 9.96
6D81.DE Per share data6D81.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
6D81 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.05
PEG (5Y)N/A
EPS Next 2Y8.32%
EPS Next 3Y8.99%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.40%, 6D81 has a reasonable but not impressive dividend return.
6D81's Dividend Yield is a higher than the industry average which is at 3.00.
Compared to an average S&P500 Dividend Yield of 2.40, 6D81 has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.4%

5.2 History

The dividend of 6D81 decreases each year by -33.98%.
Dividend Growth(5Y)-33.98%
Div Incr Years4
Div Non Decr Years4
6D81.DE Yearly Dividends per share6D81.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

6D81 has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-864%
EPS Next 2Y8.32%
EPS Next 3Y8.99%
6D81.DE Yearly Income VS Free CF VS Dividend6D81.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B

DUPONT DE NEMOURS INC

FRA:6D81 (6/18/2025, 7:00:00 PM)

58.48

+0.04 (+0.07%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners73.2%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap24.47B
Analysts81.48
Price Target76.45 (30.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.4%
Yearly Dividend1.3
Dividend Growth(5Y)-33.98%
DP-864%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.49%
Min EPS beat(2)4.98%
Max EPS beat(2)11.99%
EPS beat(4)4
Avg EPS beat(4)9.71%
Min EPS beat(4)4.98%
Max EPS beat(4)11.99%
EPS beat(8)6
Avg EPS beat(8)7.8%
EPS beat(12)10
Avg EPS beat(12)7.42%
EPS beat(16)14
Avg EPS beat(16)7.74%
Revenue beat(2)0
Avg Revenue beat(2)-2.15%
Min Revenue beat(2)-2.15%
Max Revenue beat(2)-2.14%
Revenue beat(4)1
Avg Revenue beat(4)-1.65%
Min Revenue beat(4)-3.27%
Max Revenue beat(4)0.96%
Revenue beat(8)2
Avg Revenue beat(8)-2%
Revenue beat(12)3
Avg Revenue beat(12)-1.6%
Revenue beat(16)3
Avg Revenue beat(16)-5.68%
PT rev (1m)-2.14%
PT rev (3m)-20.87%
EPS NQ rev (1m)0.46%
EPS NQ rev (3m)-4.36%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.83%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)-1.42%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-0.73%
Valuation
Industry RankSector Rank
PE 15.55
Fwd PE 14.06
P/S 2.24
P/FCF 25.19
P/OCF 16.18
P/B 1.23
P/tB 17.17
EV/EBITDA 9.96
EPS(TTM)3.76
EY6.43%
EPS(NY)4.16
Fwd EY7.11%
FCF(TTM)2.32
FCFY3.97%
OCF(TTM)3.61
OCFY6.18%
SpS26.07
BVpS47.54
TBVpS3.41
PEG (NY)2.05
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.21%
ROE -0.33%
ROCE 6.92%
ROIC 4.51%
ROICexc 4.78%
ROICexgc 16.87%
OM 17.31%
PM (TTM) N/A
GM 37.26%
FCFM 8.91%
ROA(3y)5.74%
ROA(5y)5.44%
ROE(3y)8.95%
ROE(5y)8.73%
ROIC(3y)3.52%
ROIC(5y)3.04%
ROICexc(3y)3.85%
ROICexc(5y)3.28%
ROICexgc(3y)12.84%
ROICexgc(5y)9.92%
ROCE(3y)5.39%
ROCE(5y)4.66%
ROICexcg growth 3Y25.22%
ROICexcg growth 5Y11.83%
ROICexc growth 3Y9.23%
ROICexc growth 5Y14.61%
OM growth 3Y0.59%
OM growth 5Y3.81%
PM growth 3Y-52.04%
PM growth 5Y12.01%
GM growth 3Y0.02%
GM growth 5Y0.86%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 6.43
Debt/EBITDA 1.58
Cap/Depr 51.92%
Cap/Sales 4.96%
Interest Coverage 250
Cash Conversion 51.61%
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 0.91
Altman-Z 0.97
F-Score5
WACC8.32%
ROIC/WACC0.54
Cap/Depr(3y)55.14%
Cap/Depr(5y)53.03%
Cap/Sales(3y)5.17%
Cap/Sales(5y)6.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.66%
EPS 3Y-1.04%
EPS 5Y-5.5%
EPS Q2Q%30.38%
EPS Next Y7.6%
EPS Next 2Y8.32%
EPS Next 3Y8.99%
EPS Next 5Y8.2%
Revenue 1Y (TTM)4.51%
Revenue growth 3Y-0.48%
Revenue growth 5Y-4.31%
Sales Q2Q%4.61%
Revenue Next Year3.2%
Revenue Next 2Y3.65%
Revenue Next 3Y3.98%
Revenue Next 5Y4.21%
EBIT growth 1Y28.13%
EBIT growth 3Y0.11%
EBIT growth 5Y-0.66%
EBIT Next Year29.61%
EBIT Next 3Y14.01%
EBIT Next 5Y11.26%
FCF growth 1Y10236.4%
FCF growth 3Y-3.02%
FCF growth 5YN/A
OCF growth 1Y140.44%
OCF growth 3Y-6.79%
OCF growth 5Y5.56%